Gilead Sciences, Inc. (NASDAQ:GILD) Under Analyst Spotlight

ValuEngine upgraded Gilead Sciences from a buy rating to a strong-buy rating in a research report on Thursday, September 7th. The biopharmaceutical company reported $2.20 earnings per share for the quarter, beating the Zacks' consensus estimate of $2.18 by $0.02. It improved, as 7 investors sold SBA Communications Corporation shares while 4 reduced holdings.

08/29/2017 - Gilead Sciences, Inc. had its "outperform" rating reiterated by analysts at Credit Suisse.

Contrarius Mngmt Limited accumulated 1.07 million shares. Penserra Capital Management LLC now owns 1,656 shares of the biopharmaceutical company's stock worth $112,000 after acquiring an additional 144 shares in the last quarter. Moors And Cabot reported 24,983 shares or 0.29% of all its holdings. Moreover, Creative Planning has 0% invested in the company for 300 shares.

Grandfield & Dodd Llc increased its stake in Gilead Sciences Inc (GILD) by 114.16% based on its latest 2017Q2 regulatory filing with the SEC.

About 2,283 shares traded.

Grandfield & Dodd Llc, which manages about $885.55 million and $846.29M US Long portfolio, decreased its stake in Applied Matls Inc (NASDAQ:AMAT) by 38,179 shares to 391,892 shares, valued at $16.19M in 2017Q2, according to the filing. Also, insider John C. Martin sold 73,333 shares of the company's stock in a transaction on Tuesday, August 1st. The Massachusetts-based Schwerin Boyle Capital Management Inc has invested 1.17% in the stock. Tcw Grp Incorporated has 107,444 shares for 0.03% of their portfolio. Bank Of The West who had been investing in Microsoft Corp for a number of months, seems to be bullish on the $587.45 billion market cap company. (NASDAQ:GILD) for 84,699 shares. William Blair reiterated an outperform rating on shares of Gilead Sciences in a research report on Friday, June 16th. Vetr downgraded shares of Gilead Sciences from a "buy" rating to a "hold" rating and set a $86.44 price objective for the a report on Monday, September 4th. Bank of America maintained Gilead Sciences, Inc. Parnassus Investments CA grew its stake in shares of Gilead Sciences by 37.4% in the first quarter. (NASDAQ:GILD) has "Buy" rating given on Thursday, February 25 by Citigroup. The stock has "Hold" rating by Needham on Tuesday, July 26. The shares were sold at an average price of $82.65, for a total value of $2,066,250.00. (GILD) Stock Got Its Mojo Back" on September 29, 2017, also with their article: "Why Is Cash-Rich Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by Cogan John Francis. If you are accessing this story on another domain, it was illegally stolen and republished in violation of worldwide trademark & copyright legislation. Bank of New York Mellon Corp grew its stake in shares of Gilead Sciences by 9.8% in the first quarter. August 29 investment analysts at Credit Suisse kept the company rating at "Outperform" but lowered the price expectation to $85.00 from $95.00. Another trade for 5,000 shares valued at $341,529 was made by Alton Gregg H on Monday, May 1. Following the sale, the executive vice president now directly owns 106,113 shares in the company, valued at approximately $8,051,854.44. The disclosure for this sale can be found here. Insiders have sold a total of 486,819 shares of company stock worth $39,298,919 in the last 90 days. The ROE is acquired from a corporation's financial statement and computes the profitability of the investment and how much the company employs its equity. The original version of this story can be viewed at They set a buy rating and a $79.00 price target for the company. The company has market cap of $12.21 billion. The stock was sold at an average price of $75.86, for a total transaction of $5,563,041.38. Equities research analysts expect that Gilead Sciences, Inc. will post $8.75 earnings per share for the current fiscal year. The business had revenue of $7.14 billion for the quarter, compared to the consensus estimate of $6.35 billion. Gilead Sciences had a net margin of 42.90% and a return on equity of 66.07%. The business's revenue for the quarter was down 8.2% compared to the same quarter a year ago. During the same period previous year, the firm earned $3.08 EPS. Continental Advisors Llc sold 99,300 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%.

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 29th.

Investors sentiment increased to 0.93 in Q2 2017. However, -3.90% over the last one month, 18.55% for the last quarter and year to date performance stands at 14.70%. The stock's Dividend Yield stands at 2.53%. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Gilead Sciences by 50.0% in the second quarter.

Gilead Sciences, a research biopharmaceutical firm that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.

Like this



10 October 2017
Microsoft's Cortana Comes To Skype
You can find out more details about the new Cortana integration with Skype on iOS and Android over a Microsoft at the link below. You can also ask Cortana to check your flight status, give you a stock quote, or suggest the best restaurants in your area.

10 October 2017
Al Shabaab kill Technical University of Mombasa staff
Kieng says two police officers who were in the vehicle and the driver also sustained bullet wounds and were rushed to hospital. A month ago suspected Islamic militants attacked a church in the area killing two police officers and stealing their rifles.

10 October 2017
Ronaldo favourite to retain Ballon d'Or
Ligue 1 leaders Paris Saint-Germain also saw their attacking trio of Neymar , Edinson Cavani and Kylian Mbappe among the nominees. It had replaced the FIFA World Player of the year and European footballer of the year award.

10 October 2017
It's An Honour To Receive Offer From Juventus - Emre Can
Liverpool head into the game after a run of stuttering form in the Premier League under Jurgen Klopp in recent weeks. LIVERPOOL midfielder Emre Can has named his ultimate XI.

10 October 2017
Apple releases App Store v12.6.3 with a feature missing in v12.7
If you don't care about managing apps via iTunes, stick with 12.7 version of iTunes to receive latest updates from Apple. If they saw anything they liked, users could install that app on their iPhone through the box that was running iTunes .

10 October 2017
Croatia's World Cup Dream Saved After 2:0 Win Against Ukraine!
To qualify for the world Cup, which in 2018 will be held in Russian Federation , players Andriy Shevchenko need a win in this game.

10 October 2017
Federal Bureau of Investigation begins removing belongings left after Las Vegas shooting
However, McMahill said that they found the explosive in a condition that did not resemble an improvised explosive device (IED). Danley said she was unaware of any plans Paddock had when he sent her overseas to see family in her native Philippines .

10 October 2017
Institutional Ownership Update on Western Digital Corporation (NASDAQ:WDC)
Currently, 297.9 million total shares are owned by the public and among those 294.6 million shares have been available to trade. The Company develops and manufactures a portion of the recording heads and magnetic media used in its hard drive products.

10 October 2017
Nobel victor Richard Thaler praised 'demonetisation', but damned Rs.2000 notes
In particular, his work looked at how to " nudge " people into doing more long-term planning, such as saving for a pension. A United States economist Richard Thaler has won the Nobel Prize for economics this year.

10 October 2017
Nate's rain arrives tomorrow
Factor in breezy winds and wind gusts up to 30 miles per hour at times, a rather nasty day unfolds across the state. Right now we'll say that system will exit after Thursday leading to fair skies and dry conditions to end the week.